Association between lipid testing and statin therapy in acute myocardial infarction patients

American Heart Journal

Volumn 150, Issue 3, 2005, Pages 419-425

  Ko, Dennis T ^a,b,c   Alter, David A ^a,b,c   Newman, Alice M ^c   Donovan, Linda R ^c   Tu, Jack V ^b,c  

^a Schulich Heart Centre   (Canada)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; DEMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CHOLESTEROL; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; TRIGLYCERIDES;

EID: 24944486370     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.09.057     Document Type: Article

References (28)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
2. J. Shepherd, S.M. Cobbe, and I. Ford Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group N Engl J Med 333 1995 1301 1307
3. F.M. Sacks, M.A. Pfeffer, and L.A. Moye The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
4. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study group N Engl J Med 339 1998 1349 1357
5. J.R. Downs, M. Clearfield, and S. Weis Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study JAMA 279 1998 1615 1622
6. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
7. U. Stenestrand, L Wallentin for the Swedish Register of Cardiac Intensive Care Early statin treatment following acute myocardial infarction and 1-year survival JAMA 285 2001 430 436
8. G.G. Schwartz, A.G. Olsson, and M.D. Ezekowitz Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial JAMA 285 2001 1711 1718
9. H.D. Aronow, E.J. Topol, and M.T. Roe Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study Lancet 357 2001 1063 1068
10. C.P. Cannon, E. Braunwald, and C.H. McCabe Intensive versus moderate lipid lowering with statins after acute coronary syndromes N Engl J Med 350 2004 1495 1504
11. G.C. Fonarow, W.J. French, and L.S. Parsons Use of lipid-lowering medications at discharge in patients with acute myocardial infarction: data from the National Registry of Myocardial Infarction 3 Circulation 103 2001 38 44
12. E.S. Ford, A.H. Mokdad, and W.H. Giles Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000 Circulation 107 2003 2185 2189
13. G.C. Fonarow, A. Gawlinski, and S. Moughrabi Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP) Am J Cardiol 87 2001 819 822
14. H.D. Aronow, G.M. Novaro, and M.S. Lauer In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis Arch Intern Med 163 2003 2576 2582
15. T.J. Ryan, E.M. Antman, and N.H. Brooks 1999 Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction) J Am Coll Cardiol 34 1999 890 911
16. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
17. J.A. Spertus, M.J. Radford, and N.R. Every Challenges and opportunities in quantifying the quality of care for acute myocardial infarction: summary from the Acute Myocardial Infarction working group of the American Heart Association/American College of Cardiology first scientific forum on quality of care and outcomes research in cardiovascular disease and stroke Circulation 107 2003 1681 1691
18. J.V. Tu, L.R. Donovan, and D.S. Lee Quality of cardiac care in Ontario 2004 ICES Toronto
19. D.S. Lee, P.C. Austin, and J.L. Rouleau Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model JAMA 290 2003 2581 2587
20. J.V. Tu, C.D. Naylor, and P. Austin Temporal changes in the outcomes of acute myocardial infarction in Ontario, 1992-1996 CMAJ 161 1999 1257 1261
21. J.S. Alpert, K. Thygesen, and E. Antman Myocardial infarction redefined-a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction J Am Coll Cardiol 36 2000 959 969
22. C.T. Tran, D.S. Lee, and V.F. Flintoft CCORT/CCS quality indicators for acute myocardial infarction care Can J Cardiol 19 2003 38 45
23. R.S. Rosenson Myocardial injury: the acute phase response and lipoprotein metabolism J Am Coll Cardiol 22 1993 933 940
24. R. Collins, J. Armitage, and S. Parish MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial Lancet 361 2003 2005 2016
25. D.T. Ko, M. Mamdani, and D.A. Alter Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox JAMA 291 2004 1864 1870
26. R.H. Mehta, C.K. Montoye, and M. Gallogly Improving quality of care for acute myocardial infarction: the Guidelines Applied in Practice (GAP) initiative JAMA 287 2002 1269 1276
27. J.M. Foody, S.S. Rathore, and D. Galusha Older adults with myocardial infarction not receiving optimal lipid lowering management: insights from the national AMI project Circulation Suppl II 2001 790 [abstract]
28. D.E. Wennberg, M.A. Kellett, and J.D. Dickens The association between local diagnostic testing intensity and invasive cardiac procedures JAMA 275 1996 1161 1164